GORMAN KEVIN CHARLES (Chief Executive Officer) sold 17.1% of their position (106.32K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $13.44M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/11/2025ACC: 0000914475-25-000166
DirectorOfficer· Chief Executive Officer
Since Feb 2019
-106.32K
Net shares
Net seller
$13.44M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
106.32K acquired · 212.64K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+106.32K
Price / share
$35.99
Trade value
$3.83M
% of position
20.7%
8/7/2025
514.60K→620.92K
Common Stock
Direct
Shares
−106.32K
Price / share
$126.41
Trade value
$13.44M
% of position
17.1%
8/7/2025
620.92K→514.60K
Total
Net shares
+0.00
Net value
-$9.61M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/7/2025 | M · Option Exercise | +106.32K | $35.99 | $3.83M | 20.7% | 514.60K | 620.92K |
| Common Stock Direct | 8/7/2025 | S · Sale | −106.32K | $126.41 | $13.44M | 17.1% | 620.92K | 514.60K |
| Total | +0.00 | -$9.61M | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
106.32K shares
Shares
−106.32K
Strike price
35.99
Held after
0.00
Exercisable
—
8/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock106.32K shares | 8/7/2025 | M · Option Exercise | −106.32K | 35.99 | — | 0.00 |